Page 1233 - Williams Hematology ( PDFDrive )

1208 Part IX: Lymphocytes and Plasma Cells Chapter 79: Lymphocytosis and Lymphocytopenia 1209

79. Agarwal V, Sachdev A, Lehl S, Basu S: Unusual haematological alterations in rheuma- 107. Hillmen P, Muus P, Roth A, et al: Long-term safety and efficacy of sustained eculizumab
toid arthritis. J Postgrad Med 50(1):60–61, 2004. treatment in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol
80. Prochorec-Sobieszek M, Chelstowska M, Rymkiewicz G, et al: Biclonal T-cell receptor 162(1):62–73, 2013.
gammadelta+ large granular lymphocyte leukemia associated with rheumatoid arthri- 108. Satwani P, van de Ven C, Ayello J, et al: Interleukin (IL)-15 in combination with IL-2,
tis. Leuk Lymphoma 49(4):828–831, 2008. fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord
81. Grossi A, Nozzoli C, Gheri R, et al: Pure red cell aplasia in autoimmune polyglandular blood natural killer (NK) cell and NK-cell subset expansion and NK function. Cytother-
syndrome with T lymphocytosis. Haematologica 83(11):1043–1045, 1998. apy 13(6):730–738, 2011.
82. Garcia-Suarez J, Prieto A, Reyes E, et al: Persistent lymphocytosis of natural killer cells 109. Kato T, Yoshida H, Sadfar K, et al: Steroid-free induction and preemptive antiviral
in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy. Br J Hae- therapy for liver transplant recipients with hepatitis C: A preliminary report from a
matol 89(3):653–655, 1995. prospective randomized study. Transplant Proc 37(2):1217–1219, 2005.
83. Kreutzman A, Juvonen V, Kairisto V, et al: Mono/oligoclonal T and NK cells are com- 110. Ortega M, Rovira M, Almela M, et al: Bacterial and fungal bloodstream isolates from
mon in chronic myeloid leukemia patients at diagnosis and expand during dasatinib 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol
therapy. Blood 116(5):772–782, 2010. 84(1):40–46, 2005.
84. Kreutzman A, Ladell K, Koechel C, et al: Expansion of highly differentiated CD8+ 111. Choi CM, Schmaier AH, Snell MR, Lazarus HM: Thrombotic microangiopathy in hae-
T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus matopoietic stem cell transplantation: Diagnosis and treatment. Drugs 69(2):183–198,
reactivation. Leukemia 25(10):1587–1597, 2011. 2009.
85. Tanaka H, Nakashima S, Usuda M: Rapid and sustained increase of large granular lym- 112. Lapalombella R, Andritsos L, Liu Q, et al: Lenalidomide treatment promotes CD154
phocytes and rare cytomegalovirus reactivation during dasatinib treatment in chronic expression on CLL cells and enhances production of antibodies by normal B cells
myelogenous leukemia patients. Int J Hematol 96(3):308–319, 2012. through a PI3-kinase-dependent pathway. Blood 115(13):2619–2629, 2010.
86. Nagata Y, Ohashi K, Fukuda S, et al: Clinical features of dasatinib-induced large granu- 113. Janik-Moszant A, Barc-Czarnecka M, van der Burg M, et al: Concomitant EBV-related
lar lymphocytosis and pleural effusion. Int J Hematol 91(5):799–807, 2010. B-cell proliferation and juvenile myelomonocytic leukemia in a 2-year-old child. Leuk
87. Awan FT, Johnson AJ, Lapalombella R, et al: Thalidomide and lenalidomide as new Res 32(1):181–184, 2008.
therapeutics for the treatment of chronic lymphocytic leukemia. Leuk Lymphoma 114. Horny HP, Lange K, Sotlar K, Valent P: Increase of bone marrow lymphocytes in
51(1):27–38, 2010. systemic mastocytosis: Reactive lymphocytosis or malignant lymphoma? Immuno-
88. Byrd JC, O’Brien S, James DF: Ibrutinib in relapsed chronic lymphocytic leukemia. N histochemical and molecular findings on routinely processed bone marrow biopsy
Engl J Med 369(13):1278–1279, 2013. specimens. J Clin Pathol 56(8):575–578, 2003.
89. Herman SE, Niemann CU, Farooqui M, et al: Ibrutinib-induced lymphocytosis in 115. Juneja S, Januszewicz E, Wolf M, Cooper I: Post-splenectomy lymphocytosis. Clin Lab
patients with chronic lymphocytic leukemia: Correlative analyses from a phase II study. Haematol 17(4):335–337, 1995.
Leukemia 2014. 116. Domingo P, Fuster M, Muniz-Diaz E, et al: Spurious post-splenectomy CD4 and CD8
90. Woyach JA, Smucker K, Smith LL, et al: Prolonged lymphocytosis during ibrutinib lymphocytosis in HIV-infected patients. AIDS 10(1):106–107, 1996.
therapy is associated with distinct molecular characteristics and does not indicate a 117. Vidal MA, Sebastianes C, Eizaga R, et al: [Activated recombinant factor VII for bleed-
suboptimal response to therapy. Blood 123(12):1810–1817, 2014. ing after a kidney transplant] [in Spanish]. Rev Esp Anestesiol Reanim 52(10):638–639,
91. Karandikar NJ, Hotchkiss EC, McKenna RW, Kroft SH: Transient stress lymphocytosis: 2005.
An immunophenotypic characterization of the most common cause of newly identified 118. Castelino DJ, McNair P, Kay TW: Lymphocytopenia in a hospital population—What
adult lymphocytosis in a tertiary hospital. Am J Clin Pathol 117(5):819–825, 2002. does it signify? Aust N Z J Med 27(2):170–174, 1997.
92. Thommasen HV, Boyko WJ, Montaner JS, et al: Absolute lymphocytosis associated with 119. Kalman L, Lindegren ML, Kobrynski L, et al: Mutations in genes required for T-cell
nonsurgical trauma. Am J Clin Pathol 86(4):480–483, 1986. development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and
93. Pinkerton PH, McLellan BA, Quantz MC, Robinson JB: Acute lymphocytosis severe combined immunodeficiency: HuGE review. Genet Med 6(1):16–26, 2004.
after trauma—Early recognition of the high-risk patient? J Trauma 29(6):749–751, 120. Molina IJ, Kenney DM, Rosen FS, Remold-O’Donnell E: T cell lines characterize events
1989. in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med 176(3):867–874, 1992.
94. Bosch JA, Berntson GG, Cacioppo JT, et al: Acute stress evokes selective mobilization 121. Wolday D, Tsegaye A, Messele T: Low absolute CD4 counts in Ethiopians. Ethiop Med J
of T cells that differ in chemokine receptor expression: A potential pathway linking 40 (Suppl 1):11–16, 2002.
immunologic reactivity to cardiovascular disease. Brain Behav Immun 17(4):251–259, 122. Gyrgolkay LA, Nikitin YP: Leukogram and white blood cells count in native people of
2003. Chukotka. Int J Circumpolar Health 60(4):534–539, 2001.
95. Benschop RJ, Jacobs R, Sommer B, et al: Modulation of the immunologic response to 123. Laurence J: T-cell subsets in health, infectious disease, and idiopathic CD4+ T lympho-
acute stress in humans by beta-blockade or benzodiazepines. FASEB J 10(4):517–524, cytopenia. Ann Intern Med 119(1):55–62, 1993.
1996. 124. Portman MD: Routinely test for HIV in everyone presenting with unexplained lymp-
96. Mignini F, Traini E, Tomassoni D, et al: Leucocyte subset redistribution in a human hopenia. BMJ 348:g2433, 2014.
model of physical stress. Clin Exp Hypertens 30(8):720–731, 2008. 125. Skogmar S, Schon T, Balcha TT, et al: CD4 cell levels during treatment for tuberculosis
97. Anane LH, Edwards KM, Burns VE, et al: Mobilization of gammadelta T lymphocytes (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia.
in response to psychological stress, exercise, and beta-agonist infusion. Brain Behav PLoS One 8(12):e83270, 2013.
Immun 23(6):823–829, 2009. 126. Mhmoud NA, Fahal AH, van de Sande WW: CD4+ T-lymphocytopenia in HIV-negative
98. Toft P, Tonnesen E, Svendsen P, et al: The redistribution of lymphocytes during adrena- tuberculosis patients in Sudan. J Infect 65(4):370–372, 2012.
line infusion. An in vivo study with radiolabelled cells. APMIS 100(7):593–597, 1992. 127. Al-Aska A, Al-Anazi AR, Al-Subaei SS, et al: CD4+ T-lymphopenia in HIV negative
99. Tonnesen E, Hohndorf K, Lerbjerg G, et al: Immunological and hormonal responses to tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia. Eur J
lung surgery during one-lung ventilation. Eur J Anaesthesiol 10(3):189–195, 1993. Med Res 16(6):285–288, 2011.
100. Roh EJ, Chung EH, Chang YP, et al: A case of hypersensitivity to mosquito bite asso- 128. Panesar NS: What caused lymphopenia in SARS and how reliable is the lymphokine
ciated with Epstein-Barr viral infection and natural killer cell lymphocytosis. J Korean status in glucocorticoid-treated patients? Med Hypotheses 71(2):298–301, 2008.
Med Sci 25(2):321–323, 2010. 129. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al: Epidemiological, demographic, and clin-
101. Satwani P, Bhatia M, Garvin JH Jr, et al: A Phase I study of gemtuzumab ozogami- ical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease
cin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and alloge- from Saudi Arabia: A descriptive study. Lancet Infect Dis 13(9):752–761, 2013.
neic stem cell transplantation in children with poor-risk CD33+ AML: A new targeted 130. Okada H, Kobune F, Sato TA, et al: Extensive lymphopenia due to apoptosis of unin-
immunochemotherapy myeloablative conditioning (MAC) regimen. Biol Blood Mar- fected lymphocytes in acute measles patients. Arch Virol 145(5):905–920, 2000.
row Transplant 18(2):324–329, 2012. 131. Drewry AM, Samra N, Skrupky LP, et al: Persistent lymphopenia after diagnosis of sep-
102. Geyer MB, Jacobson JS, Freedman J, et al: A comparison of immune reconstitution and sis predicts mortality. Shock 42(5):383–391, 2014.
graft-versus-host disease following myeloablative conditioning versus reduced toxic- 132. Ali S, Shahbaz AU, Nelson MD, et al: Reduced relative lymphocyte count in African-
ity conditioning and umbilical cord blood transplantation in paediatric recipients. Br J Americans with decompensated heart failure. Am J Med Sci 337(3):156–160, 2009.
Haematol 155(2):218–234, 2011. 133. Borroni G, Zaccone C, Vignati G, et al: Lymphopenia and decrease in the total number
103. Neier M, Jin Z, Kleinman C, et al: Pericardial effusion post-SCT in pediatric recipients of circulating CD3+ and CD4+ T cells during “long-term” PUVA treatment for psoria-
with signs and/or symptoms of cardiac disease. Bone Marrow Transplant 46(4):529–538, sis. Dermatologica 183(1):10–14, 1991.
2011. 134. Braat MC, Oosterhuis B, Koopmans RP, et al: Kinetic-dynamic modeling of lympho-
104. Shah N, Martin-Antonio B, Yang H, et al: Antigen presenting cell-mediated expansion cytopenia induced by the combined action of dexamethasone and hydrocortisone in
of human umbilical cord blood yields log-scale expansion of natural killer cells with humans, after inhalation and intravenous administration of dexamethasone. J Pharma-
anti-myeloma activity. PLoS One 8(10):e76781, 2013. col Exp Ther 262(2):509–515, 1992.
105. Hillmen P, Young NS, Schubert J, et al: The complement inhibitor eculizumab in par- 135. Buysmann S, van Diepen FN, Yong SL, et al: Mechanism of lymphocytopenia following
oxysmal nocturnal hemoglobinuria. N Engl J Med 355(12):1233–1243, 2006. administration of corticosteroids. Transplant Proc 27(1):871–872, 1995.
106. Krishnan SK, Hill A, Hillmen P, et al: Improving cytopenia with splenic artery embo- 136. Bloemena E, Weinreich S, Schellekens PT: The influence of prednisolone on the recir-
lization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab. Int J culation of peripheral blood lymphocytes in vivo. Clin Exp Immunol 80(3):460–466,
Hematol 98(6):716–718, 2013. 1990.

Kaushansky_chapter 79_p1199-1210.indd 1208 9/17/15 4:07 PM